Psychiatry MMC | A peer-reviewed journal providing evidence-based information to practicing clinicians

Sponsor

Free NEI Membership Offer

Receive a free two-month membership term to NEI when you register on Psychiatry (Edgemont)'s website!

Click here for more info

Join our Facebook Group


Elizabeth Klumpp's Facebook Profile

Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study

May 2009

by David V. Sheehan, MD, MBA; Harry A. Croft, MD; E. Roderich Gossen, PhD; Randy J. Levitt, PhD; Claire Brullé, MD; Sylvie Bouchard, MD, PhD; Anna Rozova, MSc, MD

Dr. Sheehan is Distinguished University Health Professor, Professor of Psychiatry, Director, Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, Tampa, Florida; Dr. Croft is Medical Director, San Antonio Psychiatric Research Center, San Antonio, Texas; Drs. Gossen, Levitt, Brullé, and Rozova are from Labopharm Inc., Laval, Québec, Canada; and Dr. Bouchard is from Lakeshore General Hospital, Montréal, Québec, Canada.

This is protected content.
:
:
Content Protected by SmartLogix

Popularity: 10% [?]

Share and Enjoy:
  • HealthRanker
  • Google Bookmarks
  • LinkedIn
  • Facebook
  • Digg
  • Yahoo! Buzz
  • StumbleUpon
  • del.icio.us
  • ThisNext

Posted in Original Research | 1 Comment »

One Response

  1. fullclar Says:

    This has been an informative read for me, as of presently I’m furthering my education in the MMHC program and I find these articles to be very informative and helpful towards completing my degree with a stronger understanding of issues that occur.

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.